PlainRecalls
ModerateClass IITerminated

FDA Devices recall · Reported April 13, 2022

Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm

Due to failure of microbial testing for total aerobic microbial count (TAMC).

Recall #
Z-0856-2022
Affected scope
156 units
Initiated
February 21, 2022
Verify with FDA Devices →
View my saved recalls

Sa3, LLC recalled Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm - a moderate-severity action.

Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm was recalled by Sa3, LLC in April 13, 2022. Reason: Due to failure of microbial testing for total aerobic microbial count (TAMC).. Check the official notice for the remedy. Verify recall #Z-0856-2022 with the FDA Devices before acting.

The recall

Sa3, LLC issued this moderate-severity FDA Devices recall-Due to failure of microbial testing for total aerobic microbial count (TAMC)..

Moderate
severity level
156 units
affected scope
Class II
classification
April 13, 2022
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-0856-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-0856-2022) was formally reported on April 13, 2022, with the manufacturer initiating the action on February 21, 2022. It is classified under Moderate severity (Class II), with a current status of Terminated. Sa3, LLC is listed as the recalling firm, operating out of Los Angeles, CA. Federal records list the affected scope as 156 units.

The documented reason for this recall is: Due to failure of microbial testing for total aerobic microbial count (TAMC). Distribution data in the federal record shows the product reached: U.S. Nationwide distribution in the states of CA, FL and GA.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 40,861 medical devices recalls on record

-1,00001,0002,0003,0004,000 20052008201120142017202020232026 1,787
Severity1902064468High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

156 units

Related Recalls

6

6 from same agency

Product description

Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm

Reason for recall

Due to failure of microbial testing for total aerobic microbial count (TAMC).

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number Z-0856-2022
Date reported April 13, 2022
Date initiated February 21, 2022
Recalling firm Sa3, LLC
Firm location Los Angeles, CA
Affected scope 156 units
Distribution U.S. Nationwide distribution in the states of CA, FL and GA.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

156 units units affected - limited or regional distribution scale.

Regional (<10K units) ✓ This recall
Multi-state (10K – 100K units) -
Large-scale (100K – 1M units) -
Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-0856-2022) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm. Recalled by Sa3, LLC. Units affected: 156 units.
Why was this product recalled?
Due to failure of microbial testing for total aerobic microbial count (TAMC).
Which agency issued this recall?
This recall was issued by the FDA Devices on April 13, 2022. Severity: Moderate. Recall number: Z-0856-2022.
Where was the recalled product distributed?
Distribution: U.S. Nationwide distribution in the states of CA, FL and GA..
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-0856-2022) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with FARADRIVE STEERABLE SHEATH CLEAR, used to facilitate access… →

Browse all Medical Devices recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported April 13, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.